Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials

BACKGROUND: Conversion from calcineurin inhibitor (CNI) therapy to a mammalian target of rapamycin (mTOR) inhibitor following kidney transplantation may help to preserve graft function. Data are sparse, however, concerning the impact of conversion on posttransplant diabetes mellitus (PTDM) or the pr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Nephrol
Principais autores: Sommerer, Claudia, Witzke, Oliver, Lehner, Frank, Arns, Wolfgang, Reinke, Petra, Eisenberger, Ute, Vogt, Bruno, Heller, Katharina, Jacobi, Johannes, Guba, Markus, Stahl, Rolf, Hauser, Ingeborg A., Kliem, Volker, Wüthrich, Rudolf P., Mühlfeld, Anja, Suwelack, Barbara, Duerr, Michael, Paulus, Eva-Maria, Zeier, Martin, Porstner, Martina, Budde, Klemens
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6146542/
https://ncbi.nlm.nih.gov/pubmed/30231851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-018-1031-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados